Uses of Rabefast - 20

Rabefast 20 is used to treat gastrointestinal problems such as peptic ulcers, gastroduodenal reflux, ... with the main ingredient being Rabeprazole sodium. Let's find out more details about the uses, usage and notes when using Rabefast 20 through the following article.

Rabefast 20 belongs to the group of gastrointestinal drugs, antacids, anti-reflux and ulcers. The drug is used in the treatment of gastroesophageal reflux disease, heartburn, and peptic ulcers.
Rabestad is manufactured at Stellapharm Joint Venture Company Limited (Vietnam), in the form of tablets with round, enteric-coated tablets, yellow, meniscus, smooth. Packed in a box of 3 blisters x 10 tablets.
Each Rabefast tablet contains the main ingredient Rabeprazole sodium along with other excipients such as: Mannitol, Light magnesium oxide, Hydroxypropyl cellulose, Magnesium stearate, Hypromellose, Polyethylene glycol, Talc, Methacrylic acid copolymers, Dibutyl phthalate, Titanium dioxide , Ferric oxide, Polyethylene glycol 6000.
Rabefast 20 is used according to the doctor's prescription and used for subjects over 1 year old.

Rabefast 20 is used in the following cases:
Progressive duodenal ulcer; Progressive benign gastric ulcer; Gastroesophageal reflux disease with fever or symptomatic ulcer; H-pylori-positive duodenal ulcer; Maintenance treatment of re-infection of gastroesophageal reflux disease with fever. Efficacy has not been demonstrated for periods exceeding 12 months of dosing.

How to use:
Rabestast 20 is taken orally. Patients should take the drug in the morning is the most appropriate. Treatment of severe gastroesophageal reflux disease:
The usual dose of rabeprazole sodium is 20 mg of rabeprazole once a day for 4 to 8 weeks. Thereafter, continue maintenance therapy with 10 mg or 20 mg rabeprazole daily depending on the patient's response. Treatment of active peptic ulcer:
The usual dose is 20 mg rabeprazole/day for 4 - 8 weeks for duodenal ulcer and 6 - 12 weeks for gastric ulcer. Zollinger - Ellison syndrome:
Initial dose of 60mg Rabeprazole/time/day, adjust dose according to patient's response. The dose may be increased to 120 mg Rabeprazole/day; When daily dose is higher than 100mg Rabeprazole should be divided into 2 times. Note: The dosages listed above are for reference purposes only and cannot be used as a substitute for the dose given in the drug leaflet or on a doctor's/pharmacist's prescription. The specific dose will depend on your health condition and how advanced the disease is. To get the right dose of Rabefast 20, patients need to consult a doctor or medical professional.

Rabefast 20 should not be used in the following cases:
Patients with hypersensitivity or allergy to Rabeprazole, Benzimidazoles (Omeprazol, Pantoprazol, Esomeprazol, Lansoprazol) or to any of the other excipients contained in the product. medicine. Do not use Rabefast 20 for pregnant and lactating women.

Rabefast 20 when combined with some of the following drugs may occur interactions such as:
There is a possibility of pharmacokinetic interaction or increased or decreased drug absorption when combining Rabeprazole with dependent drugs on gastric pH such as Ketoconazole and Digoxin. Concomitant administration of rabeprazole with sucralfate slows the absorption and bioavailability of these proton pump inhibitors. It is recommended that a proton pump inhibitor be administered at least 30 minutes prior to administration of sucralfate. Co-administration of Rabeprazole with Warfarin had no clinically important interactions in the single-dose trial, but an increase in the international normalized ratio (INR) and prothrombin time (PT) was reported in patients receiving concomitant medications. this drug. It is necessary to monitor INR and PT while using Rabeprazole. Since there are no adequate data on the incompatibility of Rabeprazole, patients should not mix this drug with other drugs. To make sure it is safe to take your medicine, please list all the medications you are taking and any other medical conditions you have with your doctor or pharmacist.

During the use of Rabefast 20, patients may experience some unwanted side effects such as:
Common side effects: headache, diarrhea, nausea and vomiting. Uncommon: rhinitis, asthenia, abdominal pain, flatulence, pharyngitis, vomiting, unexplained pain, dizziness, back pain, cough, constipation, insomnia, flu-like syndrome, bacterial infection . Rare side effects such as rash, chest pain, muscle pain, dry mouth, indigestion, irritation, drowsiness, sinusitis, bronchitis, chills, belching, leg cramps, joint pain, fever and urinary tract infection. Other more distinct side effects include: anorexia, gastritis, depression, weight gain, visual and taste disturbances, leukocytosis, sweating, increased liver enzymes, thrombocytopenia, and leukopenia. neutropenic, vesicular rash, erythema multiforme. If the patient experiences skin lesions, immediately stop taking the drug and see a doctor / pharmacist for advice and timely treatment.

Before using Rabefast 20 to treat patients, it is necessary to carefully read the instructions for use of the drug and strictly follow the instructions of the doctor / pharmacist. In addition, you can refer to some precautions when using Rabefast 20 below:
Patients need to exclude the possibility of malignancy of gastric ulcer disease. Rabefast 20 should be used with caution in people with liver failure. Symptomatic response to treatment with rabeprazole does not prevent latent gastric cancer. Taking proton pump inhibitors may increase the risk of developing an infection (such as community-acquired pneumonia). Symptomatic and asymptomatic hypomagnesaemia are rare in patients on prolonged proton pump inhibitors (usually for 3 to 1 year). In patients who are contemplating long-term treatment with a proton pump inhibitor, or who are taking a proton pump inhibitor with digoxin or other drugs that can lower blood magnesium levels, serum magnesium levels should be checked prior to administration. Initial dose with a proton pump inhibitor and periodic monitoring thereafter. Rabestad 20 contains the excipients Tartrazin lake, so it may cause allergic reactions when used. Based on data on pharmacodynamic properties and adverse events occurring with Rabeprazole, it may cause drowsiness and impaired alertness when driving or operating machinery. Therefore, caution should be exercised when using Rabeprazole in this population. There are insufficient data and tight control when using Rabestad 20 in pregnant women. Therefore, it should only be used by pregnant women when absolutely necessary. There are no precise data on whether rabeprazole is excreted in human milk. Therefore, stop breastfeeding or stop taking Rabestad 20 to ensure the safety of the baby. Above is some information to share about uses, doses and notes when using Rabestad 20. To ensure safety for your health and maximize the effectiveness of your treatment, you need to use Rabestad 20 according to instructions. exactly as directed by your doctor.